True Leaf’s mission is to advance health and wellness by pioneering safe, effective hemp and cannabis treatments that improve the quality of life for people and pets.
Invest in True Leaf Medicine
$250.00 Investment Minimum
True Leaf Medicine International Ltd.
Invest with a Purpose
True Leaf Medicine
True Leaf Pet is the first to successfully leverage the beneficial properties of hemp and other scientifically proven ingredients to create functional pet products that improve quality of life.
True Leaf Medicine is in the final stages of becoming a licensed producer of medicinal cannabis under the Canadian government’s Access to Cannabis for Medicinal Purposes Regulations (ACMPR).
True Leaf Pet
The American Pet Products Association reports that the amount of global spending on pets grew from $55.72B in 2013 to in $66.75B in 2016.
Pet Spending Growth
Become an Early Investor
Copyright © 2017 All Rights Reserved.
SEC Disclaimer: An offering statement regarding this offering has been filed with the SEC. The SEC has qualified that offering statement which only means that True Leaf Medicine Inc. may make sales of the securities described by that offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement here. You should read the offering circular before making any investment.
No money or consideration is being solicited by the information on this website or any other communication and, if sent, money will not be accepted and will be promptly returned. No offer by a potential investor to buy our securities can be accepted and, if made, any such offer can be withdrawn before qualification of this offering by the SEC. A potential investor’s indication of interest does not create a commitment to purchase the securities we are offering. Any such indication of interest may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance is given and all other requirements to accept an investment from a potential investor are met after the offering qualification date.
Forward-Looking Statements: This presentation contains forward-looking statements and management may make additional forward-looking statements in response to your questions. Such written and oral disclosures are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. Although we believe our expectations expressed in such forward-looking statements are reasonable, we cannot assure you that they will be realized. Investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the anticipated results, and therefore we refer you to a more detailed discussion of the risks and uncertainties in the Company’s filings with the Securities & Exchange Commission when available. The forward-looking statements contained in this presentation are made only as of today, and True Leaf Medicine Inc. is under no obligation to revise or update these forward-looking statements.
When you partner with True Leaf, you become part of the family. In addition to receiving shares, you will also receive some perks for supporting the company’s growth.
Your benefits could include: